Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Management of Bronchospasm with Albuterol and Ipratropium Bromide

Medication Administration Guidelines

  • Patients should take albuterol 2 puffs every 4-6 hours as needed for bronchospasm and ipratropium bromide 18mcg 2 puffs four times daily on a regular schedule for optimal management of respiratory symptoms 1, 2, 3
  • Use 2 puffs of albuterol every 4-6 hours as needed for acute bronchospasm symptoms, and may increase to 4-8 puffs during periods of worsening symptoms, but should not exceed recommended daily maximum 1, 2, 3
  • Administer 2 puffs (18mcg/puff) of ipratropium bromide four times daily on a regular schedule 1, 4
  • Potential side effects of ipratropium bromide include drying of mouth and respiratory secretions 2

Special Considerations

  • During severe exacerbations, the frequency of both medications can be temporarily increased 4, 5
  • For acute severe symptoms, albuterol can be used every 20 minutes for up to 3 doses, then every 1-4 hours as needed 4
  • Ipratropium provides additive benefit to albuterol particularly during the first few hours of an acute exacerbation 4

Monitoring and Follow-up

  • If using albuterol more than twice weekly, this indicates inadequate control and may require adjustment of controller medications 1
  • Peak flow monitoring can help assess response to therapy and detect early signs of worsening 5

Common Pitfalls to Avoid

  • Do not delay seeking medical attention if symptoms worsen despite proper use of both medications 5
  • Ensure proper inhaler technique for both medications to maximize drug delivery to the lungs 4